<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 4, 2000
--------------
Merrill Lynch & Co., Inc.
-------------------------
(Exact name of Registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 1-7182 13-2740599
-------------------------------------------------------------------------------------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
</TABLE>
4 World Financial Center, New York, New York 10080
----------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 449-1000
--------------
World Financial Center, North Tower, 250 Vesey Street, New York, New York, 10281
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
<PAGE>
Item 5. Other Events
------- -------------
Exhibits are filed herewith in connection with the Registration Statements
on Form S-3 (File Nos. 333-68747 and 333-38792) filed by Merrill Lynch & Co.,
Inc. (the "Company") with the Securities and Exchange Commission covering Senior
Debt Securities issuable under an indenture dated as of April 1, 1983, as
amended through the date hereof, between the Company and The Chase Manhattan
Bank (as so amended, the "Indenture"). The Company will issue $36,000,000
aggregate principal amount of Callable Nasdaq-100(R) Market Index Target-Term
Securities due August 3, 2007 and $34,000,000 aggregate principal amount of
Callable Market Index Target-Term Securities due August 3, 2007 based upon
Biotech HOLDRS under the Indenture. The exhibits consist of the forms of
Securities and opinions of counsel relating thereto.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
------------------------------------------------------------------
EXHIBITS
(4)(a) Instruments defining the rights of security holders,
including indentures.
Form of Merrill Lynch & Co., Inc.'s Callable Nasdaq-
100(R) Market Index Target-Term Securities due August
3, 2007.
(4)(b) Instruments defining rights of security holders,
including indentures.
Form of Merrill Lynch & Co., Inc.'s Callable Market
Index Target-Term Securities due August 3, 2007 based
upon Biotech HOLDRS.
(5)(a) & (23)(a) Opinion re: legality; consent of counsel.
Opinion of Brown & Wood LLP relating to the Callable
Nasdaq-100(R) Market Index Target-Term Securities due
August 3, 2007 (including consent for inclusion of
such opinion in this report and in Merrill Lynch &
Co., Inc.'s Registration Statements relating to such
Securities).
(5)(b) & (23)(b) Opinion of Brown & Wood LLP relating to the Callable
Market Index Target-Term Securities due August 3,
2007 based upon Biotech HOLDRS (including consent for
inclusion of such opinion in this report and in
Merrill Lynch & Co., Inc.'s Registration Statements
relating to such Securities).
2
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereto duly authorized.
MERRILL LYNCH & CO., INC.
-------------------------
(Registrant)
By: /s/ John C. Stomber
---------------------------
John C. Stomber
Senior Vice President
and
Treasurer
Date: August 4, 2000
3
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
MERRILL LYNCH & CO., INC.
EXHIBITS TO CURRENT REPORT ON
FORM 8-K DATED AUGUST 4, 2000
Commission File Number 1-7182
<PAGE>
Exhibit Index
<TABLE>
<CAPTION>
Exhibit No. Description Page
----------- ----------- ----
<S> <C> <C>
(4)(a) Instruments defining the rights of security holders,
including indentures.
Form of Merrill Lynch & Co., Inc.'s Callable Nasdaq-100(R)
Market Index Target-Term Securities due August 3, 2007.
(4)(b) Instruments defining rights of security holders, including
indentures.
Form of Merrill Lynch & Co., Inc.'s Callable Market Index Target-Term
Securities due August 3, 2007 based upon Biotech HOLDRS.
(5)(a) & (23)(a) Opinion re: legality; consent of counsel.
Opinion of Brown & Wood LLP relating to the Callable Nasdaq-
100(R) Market Index Target-Term Securities due August 3, 2007
(including consent for inclusion of such opinion in this report
and in Merrill Lynch & Co., Inc.'s Registration Statements
relating to such Securities).
(5)(b) & (23)(b) Opinion of Brown & Wood LLP relating to the Callable Market
Index Target-Term Securities due August 3, 2007 based upon
Biotech HOLDRS (including consent for inclusion of such opinion
in this report and in Merrill Lynch & Co., Inc.'s Registration
Statements relating to such Securities).
</TABLE>
